Bridgewater, MA - The online StockConsultant latest screen has found provider of drugs to for the treatment of cancer Keryx Biopharmaceuticals (NASDAQ:KERX) stock under a breakout watch above 8.81.
KERX stock price is up 4.9% to 8.42 with 89.3% higher volume and is completing a string of two strong days higher. The stock is under a breakout watch above 8.81 with a target of 10.57 for a 25.5% gain.
Read the full KERX StockConsultant Report
StockConsultant.com provides free and paid online stock consulting reports and an advanced screener on over 6000 US equities. Each detailed stock report contains easy to use technical analysis indicators, charts, and news to fine tune stock entry and exit price levels. Completing the tools is a daily "Stocks to Watch" list, a real time portfolio (show up to 35 stock charts simultaneously) and keyboard controlled QuickCharts.
Disclosure: StockConsultant.com and its employees are not registered investment advisors and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Please check with a registered investment advisor before making any investment decisions. For our full disclaimer please visit www.stockconsultant.com/disclaimerpage.html
Contact:
StockConsultant.com
[email protected]
774-281-3522
Contact Us Today
If you have questions or want to learn more about our products, our team’s here to help!
PRODUCTS